Coronary interventions

In-hospital outcomes and temporal trends of percutaneous coronary interventions for chronic total occlusion

EuroIntervention 2022;18:e929-e932. DOI: 10.4244/EIJ-D-22-00599

Spyridon Kostantinis
Spyridon Kostantinis1, MD; Bahadir Simsek1, MD; Judit Karacsonyi1, MD, PhD; Khaldoon Alaswad2, MD; Oleg Krestyaninov3, MD; Dmitrii Khelimskii3, MD; Dimitri Karmpaliotis4, MD; Farouc A. Jaffer5, MD, PhD; Jaikirshan J. Khatri6, MD; Paul Poommipanit7, MD; James W. Choi8, MD; Wissam A. Jaber9, MD; Stéphane Rinfret9, MD; William Nicholson9, MD; Mitul P. Patel10, MD; Ehtisham Mahmud10, MD; Philip Dattilo11, MD; Sevket Gorgulu12, MD; Michael Koutouzis13, MD; Ioannis Tsiafoutis13, MD; Basem Elbarouni14, MD; Abdul M. Sheikh15, MD; Barry F. Uretsky16, MD; Ahmed M. ElGuindy17, MD; Brian K. Jefferson18, MD; Taral N. Patel18, MD; Jason Wollmuth19, MD; Robert F. Riley20, MD; Stewart M. Benton Jr21, MD; Rhian E. Davies21, DO; Raj H. Chandwaney22, MD; Catalin Toma23, MD; Robert W. Yeh24, MD; Daniel R. Schimmel25, MD; Nidal Abi Rafeh26, MD; Omer Goktekin27, MD; Jimmy L. Kerrigan28, MD; Olga C. Mastrodemos1, BA; Bavana V. Rangan1, BDS, MPH; Santiago Garcia1, MD; Yader Sandoval1, MD; M. Nicholas Burke1, MD; Emmanouil Brilakis1, MD, PhD
1. Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, MN, USA; 2. Cardiovascular Division, Henry Ford Hospital Cardiology Heart Care, Detroit, MI, USA; 3. Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia; 4. Gagnon Cardiovascular Institute, Morristown Medical Center, Morristown, NJ, USA; 5. Massachusetts General Hospital, Boston, MA, USA; 6. Cleveland Clinic, Cleveland, OH, USA; 7. University Hospitals, Case Western Reserve University, Cleveland, OH, USA; 8. Texas Health Presbyterian Hospital, Dallas, TX, USA; 9. Emory University Hospital Midtown, Atlanta, GA, USA; 10. UCSD Medical Center, La Jolla, CA, USA; 11. UC Health Medical Center of the Rockies, Loveland, CO, USA; 12. Acibadem Kocaeli Hospital, Izmit, Turkey; 13. Red Cross Hospital of Athens, Athens, Greece; 14. St. Boniface General Hospital, Winnipeg, Manitoba, MB, Canada; 15. Wellstar Health System, Marietta, GA, USA; 16. Central Arkansas Veterans Healthcare System, Little Rock, AR, USA; 17. Aswan Heart Center, Magdi Yacoub Foundation, Cairo, Egypt; 18. Tristar Centennial Medical Center, Nashville, TN, USA; 19. Providence Heart and Vascular Institute, Portland, OR, USA; 20. The Christ Hospital Health Network, Cincinnati, OH, USA; 21. Wellspan York Hospital, York, PA, USA; 22. Oklahoma Heart Institute, Tulsa, OK, USA; 23. University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 24. Beth Israel Deaconess Medical Center, Boston, MA, USA; 25. Northwestern Memorial Hospital, Chicago, IL, USA; 26. North Oaks Health System, Hammond, LA, USA; 27. Memorial Bahcelievler Hospital, Istanbul, Turkey; 28. Saint Thomas Heart Hospital, Nashville, TN, USA
Introduction Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) can be highly challenging, with continually evolving equipment and techniques12. A standardisation of the definitions, techniques and the guiding principles of CTO PCI has recently been achieved through global collaboration23. We examined the evolution of the techniques, outcomes and temporal trends of CTO PCI in a diverse group of patients operators from around the world.

Methods We analysed the baseline clinical and angiographic characteristics and procedural outcomes of 10,249 CTO PCIs performed in 10,019 patients between 2012 and 2022 at 40 US and non-US centres. Data collection was recorded in a dedicated online database (PROGRESS-CTO: ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Precision medicine versus standard of care for patients with myocardial infarction with non-obstructive coronary arteries (MINOCA): rationale and design of the multicentre, randomised PROMISE trial

Latest news